Conceptio
›
non-small-cell-lung-cancer
Topic
non-small-cell-lung-cancer
Knowledge-graph topic
· documents ABOUT non-small-cell-lung-cancer across the archive
1,034
Documents about non-small-cell-lung-cancer
Documents about non-small-cell-lung-cancer
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
#628549
ClinicalTrials.gov
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
#180366
ClinicalTrials.gov
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
#146458
ClinicalTrials.gov
Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
#432876
ClinicalTrials.gov
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients
#806527
ClinicalTrials.gov
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
#353282
ClinicalTrials.gov
AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer.
#455285
NCBI PubMed Central
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
#811499
ClinicalTrials.gov
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
#253010
ClinicalTrials.gov
Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients
#272331
ClinicalTrials.gov
Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC
#321712
ClinicalTrials.gov
PD-L1 Expression in Cancer (PECan Study).
#394763
ClinicalTrials.gov
BESPOKE Study of ctDNA Guided Immunotherapy
#808104
ClinicalTrials.gov
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
#804927
ClinicalTrials.gov
A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
#835245
ClinicalTrials.gov
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
#161257
HAL (France)
Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non‑small-cell lung cancer
#194772
OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
Image 4_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff
#442373
Figshare
Image 3_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff
#442374
Figshare
Image 5_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif
#442375
Figshare
Image 6_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif
#442376
Figshare
Table 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.docx
#442377
Figshare
Image 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif
#442378
Figshare
Image 2_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif
#442379
Figshare
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
#832170
ClinicalTrials.gov
Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
#832718
ClinicalTrials.gov
The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer
#387145
ClinicalTrials.gov
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
#201759
ClinicalTrials.gov
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
#840563
ClinicalTrials.gov
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
#238089
ClinicalTrials.gov
Myeloprotection With Trilaciclib in Pan-cancer Population
#806518
ClinicalTrials.gov
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
#195321
ClinicalTrials.gov
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment
#467590
ClinicalTrials.gov
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
#460089
ClinicalTrials.gov
A lung microbial signature for postoperative recurrence in stage I-II non-small cell lung cancer.
#9077
NCBI PubMed Central
Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving Immunotherapy
#467576
ClinicalTrials.gov
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)
#812270
ClinicalTrials.gov
RAPA-201 Therapy of Solid Tumors
#426773
ClinicalTrials.gov
Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study
#28477
ClinicalTrials.gov
Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
#238123
ClinicalTrials.gov
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
#832354
ClinicalTrials.gov
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
#830930
ClinicalTrials.gov
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
#806925
ClinicalTrials.gov
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
#180406
ClinicalTrials.gov
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
#172287
ClinicalTrials.gov
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
#172320
ClinicalTrials.gov
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
#314317
ClinicalTrials.gov
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations
#314339
ClinicalTrials.gov
A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer
#125859
ClinicalTrials.gov
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
#127585
ClinicalTrials.gov
← Previous
Page 11 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.